Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashu Rastogi

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
JAMA Network Open|May 15, 2023
Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical TrialAshu Rastogi, Sudhir A Kulkarni, Sanjay Agarwal, et al.
Journal of Clinical Lipidology|December 28, 2022
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of IndiaRaman Puri, Vimal Mehta, P Barton Duell, et al.
The Journal of the Association of Physicians of India|September 9, 2022
Unmet Need for Further LDL-C Lowering in India despite Statin Therapy: Lipid Association of India Recommendations for the Use of Bempedoic AcidVimal Mehta, Raman Puri, P Barton Duell, et al.
The Lancet Regional Health. Southeast Asia|April 6, 2026
A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver StudyAshish Kumar, Jayant K Panda, Prabhat Agrawal, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
JAMA Network Open|May 15, 2023
Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical TrialAshu Rastogi, Sudhir A Kulkarni, Sanjay Agarwal, et al.
Journal of Clinical Lipidology|December 28, 2022
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of IndiaRaman Puri, Vimal Mehta, P Barton Duell, et al.
The Journal of the Association of Physicians of India|September 9, 2022
Unmet Need for Further LDL-C Lowering in India despite Statin Therapy: Lipid Association of India Recommendations for the Use of Bempedoic AcidVimal Mehta, Raman Puri, P Barton Duell, et al.
The Lancet Regional Health. Southeast Asia|April 6, 2026
A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver StudyAshish Kumar, Jayant K Panda, Prabhat Agrawal, et al.
Pageof 12